Sfoglia per Rivista NEUROLOGICAL SCIENCES
Migraine and movement disorders
2012-01-01 D'Onofrio, F; Barbanti, P; Petretta, V; Casucci, G; Mazzeo, A; Lecce, B; Mundi, C; Cologno, D
Migraine prophylaxis: what is new and what we need?
2011-01-01 Barbanti, P; Aurilia, C; Egeo, G; Fofi, L
Migraineurs' psychological traits do not influence response to erenumab
2020-01-01 Altamura, C; Costa, C; Fofi, L; Viticchi, G; Fallacara, A; Brunelli, N; Egeo, G; Aurilia, C; Migliore, S; Barbanti, P; Silvestrini, M; Vernieri, F.
Modification of respiratory function parameters in patients with severe Parkinson's disease
2002-01-01 De Pandis, Mf; Starace, A; Stefanelli, F; Marruzzo, P; Meoli, I; De Simone, G; Prati, R; Stocchi, F
Multiple sclerosis: pharmacogenomics and personalised drug treatment
2006-01-01 V, Annibali; G, Ristori; S, Cannoni; S, Romano; A, Visconti; A, Ghazaryan; L, FIGÀ TALAMANCA; M, Salvetti; Mechelli, R.
Non-invasive vagus nerve stimulation (nVNS) as symptomatic treatment of migraine in young patients: a preliminary safety study
2017-01-01 Grazzi, L; Egeo, G; Liebler, E; Padovan, Am; Barbanti, P
Observational study of sleep-related disorders in Italian patients with Parkinson’s disease: usefulness of the Italian version of Parkinson’s disease sleep scale
2012-01-01 Pellecchia, Mt; Antonini, A; Bonuccelli, U; Fabbrini, G; Ferini Strambi, L; Stocchi, F; Battaglia, A; Barone, P
Optimizing levodopa pharmacokinetics in Parkinson's disease: the role of COMT inhibitor
2003-01-01 Stocchi, F; Vacca, L; Grassini, P; Battaglia, G; Onofrj, M; Valente, M; Ruggieri, S
Rationale for use of onabotulinum toxin A (BOTOX) in chronic migraine
2015-01-01 Barbanti, P; Egeo, G; Fofi, L; Aurilia, C; Piroso, S
Restless legs syndrome is not associated with migraine with aura: a clinical study
2011-01-01 D'Onofrio, F; Cologno, D; Petretta, V; Finocchi, C; Autunno, M; Marsala, G; Usai, S; Grazzi, L; Omboni, S; Fofi, L; Barbanti, P; Bussone, G
Role of neurostimulation in migraine
2015-01-01 Grazzi, L; Padovan, A; Barbanti, P
Subcutaneous continuous apomorphine infusion in fluctuating patients with Parkinson's disease: long-term results
2001-01-01 Stocchi, F; Vacca, L; De Pandis, Mf; Barbato, L; Valente, M; Ruggieri, S.
The role of anti-CGRP antibodies in the pathophysiology of primary headaches
2017-01-01 Barbanti, P; Aurilia, C; Fofi, L; Egeo, G; Ferroni, P
Treatment of tension-type headache: from old myths to modern concepts
2014-01-01 Barbanti, P; Egeo, G; Aurilia, C; Fofi, L
Use of Apomorphine in Parkinson’s Disease
2008-01-01 Stocchi, F
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Migraine and movement disorders | 1-gen-2012 | D'Onofrio, F; Barbanti, P; Petretta, V; Casucci, G; Mazzeo, A; Lecce, B; Mundi, C; Cologno, D | |
Migraine prophylaxis: what is new and what we need? | 1-gen-2011 | Barbanti, P; Aurilia, C; Egeo, G; Fofi, L | |
Migraineurs' psychological traits do not influence response to erenumab | 1-gen-2020 | Altamura, C; Costa, C; Fofi, L; Viticchi, G; Fallacara, A; Brunelli, N; Egeo, G; Aurilia, C; Migliore, S; Barbanti, P; Silvestrini, M; Vernieri, F. | |
Modification of respiratory function parameters in patients with severe Parkinson's disease | 1-gen-2002 | De Pandis, Mf; Starace, A; Stefanelli, F; Marruzzo, P; Meoli, I; De Simone, G; Prati, R; Stocchi, F | |
Multiple sclerosis: pharmacogenomics and personalised drug treatment | 1-gen-2006 | V, Annibali; G, Ristori; S, Cannoni; S, Romano; A, Visconti; A, Ghazaryan; L, FIGÀ TALAMANCA; M, Salvetti; Mechelli, R. | |
Non-invasive vagus nerve stimulation (nVNS) as symptomatic treatment of migraine in young patients: a preliminary safety study | 1-gen-2017 | Grazzi, L; Egeo, G; Liebler, E; Padovan, Am; Barbanti, P | |
Observational study of sleep-related disorders in Italian patients with Parkinson’s disease: usefulness of the Italian version of Parkinson’s disease sleep scale | 1-gen-2012 | Pellecchia, Mt; Antonini, A; Bonuccelli, U; Fabbrini, G; Ferini Strambi, L; Stocchi, F; Battaglia, A; Barone, P | |
Optimizing levodopa pharmacokinetics in Parkinson's disease: the role of COMT inhibitor | 1-gen-2003 | Stocchi, F; Vacca, L; Grassini, P; Battaglia, G; Onofrj, M; Valente, M; Ruggieri, S | |
Rationale for use of onabotulinum toxin A (BOTOX) in chronic migraine | 1-gen-2015 | Barbanti, P; Egeo, G; Fofi, L; Aurilia, C; Piroso, S | |
Restless legs syndrome is not associated with migraine with aura: a clinical study | 1-gen-2011 | D'Onofrio, F; Cologno, D; Petretta, V; Finocchi, C; Autunno, M; Marsala, G; Usai, S; Grazzi, L; Omboni, S; Fofi, L; Barbanti, P; Bussone, G | |
Role of neurostimulation in migraine | 1-gen-2015 | Grazzi, L; Padovan, A; Barbanti, P | |
Subcutaneous continuous apomorphine infusion in fluctuating patients with Parkinson's disease: long-term results | 1-gen-2001 | Stocchi, F; Vacca, L; De Pandis, Mf; Barbato, L; Valente, M; Ruggieri, S. | |
The role of anti-CGRP antibodies in the pathophysiology of primary headaches | 1-gen-2017 | Barbanti, P; Aurilia, C; Fofi, L; Egeo, G; Ferroni, P | |
Treatment of tension-type headache: from old myths to modern concepts | 1-gen-2014 | Barbanti, P; Egeo, G; Aurilia, C; Fofi, L | |
Use of Apomorphine in Parkinson’s Disease | 1-gen-2008 | Stocchi, F |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile